Selenomethionine induces p53 mediated cell cycle arrest and apoptosis in human colon cancer cells

Cancer Biology & Therapy
Ajay GoelC Richard Boland

Abstract

While there is an increasing interest in selenium chemoprevention against human colon polyp recurrence and other cancers, the mechanism(s) by which these agents inhibit carcinogenesis are uncertain. Some of the proposed mechanisms include the inhibition of cytosine methyltransferases, carcinogen bioactivation, and inhibition of cyclooxygenase (COX). More recently, it has been suggested that selenium may exert growth inhibitory effects by activating p53. However, the molecular mechanisms of action of selenomethionine, an organoselenium compound present in selenized yeast and currently being investigated in human clinical trials for colon polyp prevention, are unclear. In the present study we tested the hypothesis that selenomethionine might affect colon cancer cell growth by p53 mediated apoptosis and/or cell cycle regulation. Four human colon cancer cell lines including HCT116 and RKO (wild type p53), HCT116-p53KO (isogenic control of HCT116 cells with p53 knocked out) and Caco-2 (mutant p53) were treated with 0-100 microM of selenomethionine for 24, 48 and 72 h. Cell viability rates were determined by the MTT assay. Cell cycle analysis was performed by flow cytometry and apoptosis measured by Annexin V-Cy5 staining. Expression...Continue Reading

Citations

Dec 25, 2009·Archives of Toxicology·Vanessa ValdiglesiasBlanca Laffon
Jun 23, 2001·Molecular and Biochemical Parasitology·S F VillamilA Stoppani
Jan 1, 2010·Nutrition and Cancer·Meredith A KatoThomas J Fahey
Jan 14, 2009·Cancer Prevention Research·Kristin WallaceMargaret R Karagas
Jan 25, 2011·Radiation and Environmental Biophysics·Amit KunwarK I Priyadarsini
Nov 26, 2015·Nutrition and Cancer·Junxuan LüMaarten C Bosland
Dec 15, 2010·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Wen-Hsuan LiVivian Hsiu-Chuan Liao
Dec 18, 2007·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·W D JohnsonD L McCormick
Oct 10, 2007·Journal of Pediatric Surgery·Anna R IbeleDennis P Lund
Jun 13, 2008·Chemico-biological Interactions·Yun-Feng Zhao, Qing-Zhong Kong
Jul 22, 2015·In Vitro Cellular & Developmental Biology. Animal·Meijun LongWanshou Qiu
Dec 3, 2014·Biochimica Et Biophysica Acta·Aristi P Fernandes, Valentina Gandin
Nov 16, 2016·Antioxidants·Hans VergauwenChris van Ginneken
Oct 30, 2007·Bioorganic & Medicinal Chemistry Letters·Daniel PlanoJuan Antonio Palop
Dec 10, 2016·Chemical Communications : Chem Comm·Pedro M S D CalGonçalo J L Bernardes
Nov 16, 2007·Journal of Cellular Biochemistry·Eung-Ryoung LeeSsang-Goo Cho
Sep 24, 2009·European Journal of Gastroenterology & Hepatology·Asghar Qasim, Colm O'Morain
Jun 9, 2017·Journal of Nanobiotechnology·Praveen Sonkusre, Swaranjit Singh Cameotra
Mar 1, 2012·Biomolecules & Therapeutics·Xiao-Hong ZhangYun-Feng Zhao
Jan 24, 2007·Molecular Cancer Therapeutics·Joshua L FischerMartin L Smith
Aug 8, 2021·International Journal of Molecular Sciences·Waqas AlamCarla Renata Arciola

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.